PerkinElmer Inc. provides products, services, & solutions to the diagnostics, research, environmental, industrial, & laboratory services markets worldwide. It operates through two segments, Human Health & Environmental Health. The Human Health segment develops diagnostics, tools, & applications to help detect diseases earlier, & to accelerate the discovery & development of critical new therapies. It provides early detection for genetic disorders from pregnancy to early childhood, well as flat panel X-ray detectors & infectious disease testing for the diagnostics market; & a suite of solutions, including reagents, liquid handling systems, & detection & imaging technologies that enable scientists to enhance life sciences research & drug discovery processes. This segment’s research portfolio includes instrumentation for automation & detection solutions, & in vitro & in vivo imaging & analysis hardware & software; & a portfolio of consumable products, including drug discovery & research reagents. The Environmental Health segment provides products, services, & solutions to facilitate the creation of safer food & consumer products. It develops & provides analytical technologies, solutions, & services that enable its customers to understanding the characterization & health of various aspects, including air, water, soil, & food. This segment also provides analytical instrumentation for the industrial market, which includes the chemical, petrochemical, lubricant, polymer, electronics, pharmaceutical, & food & dietary supplement industries; & laboratory services. It serves pharmaceutical & biotechnology companies, laboratories, academic & research institutions, public health authorities, private healthcare organizations, doctors, & government agencies. PerkinElmer Inc. was formerly known as EG&G, Inc. & changed its name to PerkinElmer, Inc. in October, 1999. It was founded in 1931 & is headquartered in Waltham, Massachusetts.